Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 2,069 | 1,525 | 1,822 | -4,551 | 535 |
| Cost of Goods | 993 | 734 | 1,002 | -3,552 | 685 |
| Gross Profit | 1,076 | 791 | 820 | -999 | -150 |
| Operating Expenses | 5,711 | 2,235 | 1,969 | -3,568 | 3,834 |
| Operating Income | -3,642 | -710 | -1,147 | 2,017 | -3,299 |
| Interest Expense | 200 | 514 | 615 | -4 | 82 |
| Other Income | -943 | 257 | 26 | 934 | -56 |
| Pre-tax Income | -4,785 | -967 | -1,736 | 2,955 | -3,437 |
| Income Tax | N/A | -512 | N/A | N/A | N/A |
| Net Income Continuous | -4,785 | -455 | -1,736 | 2,955 | -3,437 |
| Net Income Discontinuous | 6,760 | -3,318 | -2,881 | -6,720 | -5,082 |
| Net Income | $1,975 | $-3,773 | $-4,617 | $-3,765 | $-8,519 |
| EPS Basic Total Ops | 4.90 | -9.90 | -14.15 | -21.71 | -46.70 |
| EPS Basic Continuous Ops | -11.90 | -1.20 | -5.30 | 15.98 | -18.85 |
| EPS Basic Discontinuous Ops | 16.80 | -8.70 | -8.85 | -36.98 | -27.85 |
| EPS Diluted Total Ops | 4.90 | -9.90 | -14.15 | -21.71 | -46.70 |
| EPS Diluted Continuous Ops | -11.90 | -1.20 | -5.30 | 15.98 | -18.85 |
| EPS Diluted Discontinuous Ops | 16.80 | -8.70 | -8.85 | -36.98 | -27.85 |
| EBITDA(a) | $-609 | $-508 | $-535 | $2,488 | $-3,078 |